421 results match your criteria: "Children's Hospital of New York-Presbyterian[Affiliation]"
Pediatr Cardiol
October 2016
Department of Cardiology, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Endomyocardial biopsy (EMB) is a common procedure used to aid in the diagnosis, prognosis and treatment of suspected pediatric cardiomyopathy. In suspected cardiomyopathy, no multicenter experience has previously reported on the safety and utility of EMBs. Retrospectively, adverse event (AE) and patient and procedural characteristics were obtained at seven institutions participating in the Congenital Cardiac Catheterization Outcomes Project for both a cardiomyopathy (n = 158) and a post-transplant surveillance (n = 2665) cohort.
View Article and Find Full Text PDFPediatr Cardiol
August 2016
Division of Pediatric Cardiology, Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital of New York-Presbyterian, 3959 Broadway, Room 255, New York, NY, 10032, USA.
After pulmonary artery (PA) patch augmentation, surgical or catheterization reintervention to address PA stenosis is not uncommon. Multiple patch materials are available and the need for reintervention may be related to characteristics of the patch material. In this retrospective chart review of patients who underwent PA augmentation from 2004 through 2013, we compare outcomes after PA augmentation with standard patch (SP) material and extracellular matrix (ECM) patch material.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
May 2016
Congenital and Pediatric Cardiac Surgery, Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY.
Pediatr Cardiol
June 2016
Pediatric Cardiac Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University, New York, NY, USA.
Hum Genet
May 2016
Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Rm. R809, Houston, TX, 77030, USA.
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal lung developmental disorder caused by heterozygous point mutations or genomic deletion copy-number variants (CNVs) of FOXF1 or its upstream enhancer involving fetal lung-expressed long noncoding RNA genes LINC01081 and LINC01082. Using custom-designed array comparative genomic hybridization, Sanger sequencing, whole exome sequencing (WES), and bioinformatic analyses, we studied 22 new unrelated families (20 postnatal and two prenatal) with clinically diagnosed ACDMPV. We describe novel deletion CNVs at the FOXF1 locus in 13 unrelated ACDMPV patients.
View Article and Find Full Text PDFJ Robot Surg
September 2016
Division of Pediatric Urology, Columbia University Medical Center, Morgan Stanley Children's Hospital of New York Presbyterian, New York, NY, USA.
With increased experience, many laparoscopic procedures have evolved from mandatory same-day admission to the outpatient setting. Given the shorter operative time and length of stay, the potential to perform robotic surgery as an outpatient procedure exists. We sought to describe our initial experience with performing robotic-assisted laparoscopic pyeloplasty (RP) on children in an outpatient setting.
View Article and Find Full Text PDFPediatr Crit Care Med
March 2016
1Division of Pediatric Cardiology, Department of Pediatrics, Rady Children's Hospital San Diego, UC San Diego School of Medicine, San Diego, CA. 2Department of Pharmacy, Texas Children's Hospital, Houston, TX. 3Division of Cardiology, Department of Pediatric Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, TX. 4Department of Pharmacy, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, New York, NY.
Objective: In this Consensus Statement, we review the etiology and pathophysiology of inflammatory processes seen in critically ill children with cardiac disease. Immunomodulatory therapies aimed at improving outcomes in patients with myocarditis, heart failure, and transplantation are extensively reviewed.
Data Sources: The author team experience and along with an extensive review of the medical literature were used as data sources.
Pediatr Cardiol
June 2016
Pediatric Cardiac Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University, New York, NY, USA.
Pulmonary valve (PV) incompetence following transannular patch (TAP) repair of tetralogy of Fallot (TOF) results in long-term morbidity and mortality. Valve-sparing repairs have recently gained recognition; however, they may be associated with residual pulmonary stenosis (PS) in patients with small PV z scores. We sought to determine whether a repair that increases the PV annulus and augments the valve leaflet with a biomaterial would result in annular growth and in longer duration of valve competence compared with TAP.
View Article and Find Full Text PDFJ Clin Rheumatol
March 2016
From the *Division of Pediatric Rheumatology, Cohen Children's Medical Center, Lake Success, NY; †Chicago College of Pharmacy, Midwestern University, Downers Grove, IL; and ‡Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center; §College of Pharmacy and Health Professions, St John's University, Jamaica; ∥Division of Rheumatology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY.
Background/objectives: Mycophenolate mofetil (MMF) is used to treat pediatric-onset lupus nephritis (pLN). Data are equivocal on the use of plasma mycophenolic acid (MPA) levels as a measure of efficacy and predictor of therapeutic outcomes in pLN. Glucuronidated MPA (MPA-G) is an inactive metabolite that is a marker of adequate absorption and normal metabolism of MMF.
View Article and Find Full Text PDFPediatr Blood Cancer
May 2016
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
Background: Splenic dysfunction is a significant complication of sickle cell disease (SCD). Hematopoietic stem cell transplant (HSCT) is a proven cure for SCD; however, its long-term effect on splenic function is not well characterized.
Procedure: We conducted a retrospective cohort study of pediatric patients who had HSCT for SCD at two transplant centers.
J Pediatric Infect Dis Soc
December 2014
Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, New York Department of Infection Prevention and Control.
We compared measles, mumps, rubella (MMR), and influenza vaccination rates of children presenting to a Pediatric Emergency Department (PED) in New York City with rates from national assessments. MMR and influenza vaccination rates in this PED population were generally comparable to community rates, but lower than Healthy People 2020 targets.
View Article and Find Full Text PDFJ Rheumatol
December 2015
From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone MedicalCenter; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone MedicalCenter; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical
Objective: To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE).
Methods: Invitations to participate and complete a 1-page questionnaire for each patient prescribed belimumab were sent to 16 physicians experienced in SLE phase III clinical trials.
J Thorac Cardiovasc Surg
January 2016
Department of Surgery, Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY. Electronic address:
Endocr Rev
October 2015
Department of Obstetrics and Gynecology (D.A.D.), David Geffen School of Medicine at UCLA, Los Angeles, California 90095; Division of Pediatric Endocrinology (S.E.O.), Children's Hospital of New York-Presbyterian, Columbia University College of Physicians and Surgeons, New York, New York 10032; Department of Physiology (E.S.-V.), Karolinska Institutet, 171 77 Stockholm, Sweden; Center for Research in Reproduction and Division of Endocrinology (J.C.M.), Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia 22903; Division of Reproductive Medicine (J.S.L.), Department of Obstetrics and Gynecology, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands; and Department of Obstetrics and Gynecology (R.S.L.), Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033.
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both adverse reproductive and metabolic implications for affected women. However, there is generally poor understanding of its etiology. Varying expert-based diagnostic criteria utilize some combination of oligo-ovulation, hyperandrogenism, and the presence of polycystic ovaries.
View Article and Find Full Text PDFSemin Fetal Neonatal Med
December 2015
Columbia University Medical Center, Division of Neonatology, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY, USA.
Given the overwhelming size of the neonatal literature, clinicians must rely upon expert panels such as the Committee on Fetus and Newborn in the USA and the National Institute for Healthcare and Excellence in the UK for guidance. Guidelines developed by expert panels are not equivalent to evidence-based medicine and are not rules, but do provide evidence-based recommendations (when possible) and at minimum expert consensus reports. The standards used to develop evidence-based guidelines differ among expert panels.
View Article and Find Full Text PDFClin Rev Allergy Immunol
June 2018
Department of Medicine, Weill Cornell Medical Center, New York, NY, USA.
Anaphylaxis is a dramatic expression of systemic allergy. The lifetime prevalence of anaphylaxis is currently estimated at 0.05-2 % in the USA and ~3 % in Europe.
View Article and Find Full Text PDFTher Adv Musculoskelet Dis
August 2015
Division of Adult Rheumatology, New York Presbyterian Hospital, Columbia University Medical Center, 630 W 168th St, P&S Building, 10th floor, New York, NY 10032, USA.
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B-lymphocyte stimulator (also known as B cell activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration and the European Medicines Evaluation Agency for treatment of autoantibody-positive systemic lupus erythematosus (SLE) in adults. This review discusses the key findings of the phase III trials, post hoc analyses, and real-world postmarketing use of belimumab in the routine care of SLE patients. It also highlights the safety profile of belimumab and gives insight into its potential use to treat childhood-onset SLE.
View Article and Find Full Text PDFCirculation
August 2015
From Boston Children's Hospital, Department of Cardiology, Harvard Medical School, Department of Pediatrics, MA (L.R.F., M.C.E.-D., R.K., W.T.); Boston Children's Hospital, Department of Medicine, Harvard Medical School, Department of Pediatrics, MA (B.T.K.); Primary Children's Hospital, University of Utah School of Medicine, Department of Pediatrics, Division of Cardiology, Salt Lake City (M.D.P.); Hospital for Sick Children, University of Toronto Faculty of Medicine, Department of Pediatrics, Division of Cardiology, ON, Canada (E.T.J.); Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Department of Pediatrics, Division of Cardiology, PA (A.L.S.); All Children's Hospital, Johns Hopkins Medicine, Department of Pediatrics, Division of Cardiology, St. Petersburg, FL (G.F.); Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, Department of Pediatrics, Division of Cardiology, New York (S.M.L.); Monroe Carell Jr. Children's Hospital, Vanderbilt University School of Medicine, Department of Pediatrics, Division of Cardiology, Nashville, TN (A.K.-M.); Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Department of Pediatrics, The Heart Institute, OH (E.C.M.); UCSF Benioff Children's Hospital, University of California-San Francisco School of Medicine, Department of Pediatrics, Division of Cardiology (A.J.M.-G., N.H.S.); Children's National Medical Center, Division of Cardiology, George Washington University School of Medicine and Health Sciences, Department of Pediatrics, Washington, DC (M.T.D.); Heart Institute Children's Hospital Colorado, University of Colorado School of Medicine, Department of Pediatrics, Division of Cardiology, Aurora (L.W.H.); Lucile Packard Children's Hospital, Stanford School of Medicine, Department of Pediatrics, Division of Cardiology, Palo, Alto, CA (E.S.S.T., N.H.S., D.B.M.); Advocate Children's Hospital, Oak
Background: Ebstein anomaly and tricuspid valve dysplasia are rare congenital tricuspid valve malformations associated with high perinatal mortality. The literature consists of small, single-center case series spanning several decades. We performed a multicenter study to assess the outcomes and factors associated with mortality after fetal diagnosis in the current era.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2015
Department of Cardiology, Boston Children's Hospital, Boston Massachusetts, Children's Hospital Boston, Boston, Massachusetts.
Objective: To describe contemporary outcomes of balloon aortic valvuloplasty (BAVP) performed in 22 US centers.
Background: BAVP constitutes first-line therapy for congenital aortic stenosis (cAS) in many centers.
Methods: We used prospectively-collected data from two active, multi-institutional, pediatric cardiac catheterization registries.
Ann Thorac Surg
July 2015
Pediatric Cardiac Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University, New York, New York. Electronic address:
Background: Hospital mortality of stage I palliation in patients with hypoplastic left heart syndrome and weighing less than or equal to 2.5 kg remains high. We aimed to (1) assess outcomes in this specific population in a dedicated neonatal cardiac program and (2) determine factors associated with poor outcomes.
View Article and Find Full Text PDFCongenit Heart Dis
May 2016
Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center, New York, NY, USA.
Introduction: Heart transplant recipients are at risk for developing left ventricular (LV) dysfunction. While traditional echocardiographic parameters have limitations, speckle tracking echocardiography (STE) is a novel technique shown to be more sensitive and accurate in adult studies for evaluating ventricular systolic and diastolic function.
Design: Pediatric heart transplant recipients undergoing routine cardiac catheterization were included.
Pediatr Cardiol
October 2015
Division of Cardiothoracic Surgery, Department of Surgery, Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY, USA.
We reviewed our experience of surgical repair of Tetralogy of Fallot (TOF) in children weighing less than or equal to 4 kg to compare outcome of early palliation versus complete repair as the initial surgical approach. Seventy-six patients, weighing ≤ 4 kg, with TOF surgery between January 2005 and September 2013 were included in this single-center retrospective study. Twenty-five patients who underwent initial shunt procedure followed by later full repair were compared to 51 patients who had primary full repair for differences in baseline characteristics and outcomes.
View Article and Find Full Text PDFJAMA Pediatr
May 2015
Department of Emergency Medicine, University of California, Davis, School of Medicine, Sacramento6University of California, Davis, Medical Center, Sacramento.
Pediatr Cardiol
August 2015
Division of Pediatric Cardiology, Department of Pediatrics, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, 3959 Broadway, New York, NY, 10032, USA,
We evaluated differences in growth between fetuses with and without congenital heart disease (CHD) and tested associations between growth and early childhood neurodevelopment (ND). In this prospective cohort study, fetuses with hypoplastic left heart syndrome (HLHS), transposition of the great arteries (TGA), and tetralogy of Fallot (TOF) and controls had biparietal diameter (BPD), head (HC) and abdominal circumference (AC), femur length (FL), and estimated fetal weight (EFW) recorded serially during pregnancy at 18-26 weeks GA (F1), at 27-33 weeks GA (F2), and at 34-40 weeks GA (F3). CHD subjects underwent Bayley Scales of Infant Development-III ND testing at 18 months.
View Article and Find Full Text PDF